Advisor OS’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$566K Buy
9,328
+716
+8% +$41.7K 0.04% 279
2025
Q4
$465K Buy
8,612
+1,072
+14% +$51.6K 0.04% 290
2025
Q3
$340K Buy
7,540
+9
+0.1% +$420 0.03% 347
2025
Q2
$349K Buy
7,531
+1,537
+26% +$75.4K 0.03% 324
2025
Q1
$366K Buy
5,994
+537
+10% +$31.3K 0.04% 285
2024
Q4
$309K Buy
5,457
+1,267
+30% +$70.8K 0.04% 315
2024
Q3
$217K Buy
+4,190
New +$197K 0.02% 379
2024
Q2
Sell
-6,679
Closed -$362K 391
2024
Q1
$362K Buy
6,679
+763
+13% +$38.9K 0.04% 279
2023
Q4
$304K Sell
5,916
-2,127
-26% -$112K 0.04% 257
2023
Q3
$467K Sell
8,043
-2,758
-26% -$169K 0.07% 194
2023
Q2
$691K Buy
10,801
+6,414
+146% +$430K 0.11% 172
2023
Q1
$304K Sell
4,387
-175
-4% -$12.3K 0.07% 190
2022
Q4
$328K Buy
4,562
+867
+23% +$65.4K 0.09% 174
2022
Q3
$262K Buy
3,695
+63
+2% +$4.57K 0.08% 169
2022
Q2
$280K Buy
3,632
+235
+7% +$17.9K 0.08% 178
2022
Q1
$248K Sell
3,397
-1,805
-35% -$121K 0.07% 186
2021
Q4
$323K Sell
5,202
-52
-1% -$3.05K 0.07% 204
2021
Q3
$311K Sell
5,254
-107
-2% -$7.05K 0.07% 194
2021
Q2
$359K Buy
+5,361
New +$350K 0.07% 173
2021
Q1
Sell
-7,718
Closed -$360K 197
2020
Q4
$360K Buy
+7,718
New +$475K 0.1% 98

Other funds holding BMY

Advisor OS's BMY Position: Q1 2026 in Review

Advisor OS increased its Bristol-Myers Squibb (BMY) stake by 8.3% in Q1 2026, buying an estimated $41.7K and bringing the position to 9,328 shares worth $566K. The position accounts for 0.04% of the portfolio, ranked #279.

Advisor OS first reported a position in BMY in Q4 2020 and has held it in 20 quarters since. The position peaked at $691K in Q2 2023. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Advisor OS held 9,328 shares of Bristol-Myers Squibb worth $566K as of Q1 2026.
  • Advisor OS bought 716 Bristol-Myers Squibb shares in Q1 2026, an estimated $41.7K.
  • Bristol-Myers Squibb made up 0.04% of Advisor OS's portfolio in Q1 2026, its #279 holding.
  • Advisor OS first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 20 quarters since.
  • Advisor OS's Bristol-Myers Squibb position peaked at $691K in Q2 2023.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Advisor OS's 13F filing for Q1 2026, filed 8 May 2026.